MAX has tumour suppressor roles in a small subset of hereditary pheochromocytomas and in small cell lung cancer21, 22, and a recent report demonstrated MAX mutation in one KIT/PDGFRA wild-type, NF1-mutant, GIST23. Here, PDGFRA is linked to neoplasm.